DualTPharma

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Bactheravax

This company develops therapeutic vaccines targeting tumour-associated bacteria to improve treatment sensitivity and immune responses for patients with colorectal and other cancers.

Neobe

The company develops engineered microbial biotherapeutics designed to disrupt the microenvironment of solid tumours for cancer patients receiving immunotherapy.

Exomnis Biotech

This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.

Captain T Cell

The company develops cell therapies for cancer patients to treat solid tumours.

BRENUS PHARMA

This company develops allogeneic cancer immunotherapies for patients with solid tumors using a proteomics-guided platform that mimics tumor cell resistance and escape mechanisms.

CHAIN Biotech

This biotechnology company develops oral vaccines and microbiome therapeutics using engineered bacteria to treat solid tumour cancers and chronic diseases for pharmaceutical partners.

Iscaff Pharma

This company develops patient-derived tumor scaffolds for pharmaceutical firms to improve the pre-clinical validation and development of aggressive cancer treatments.